TechCrunch Startup News
TechCrunch Startup News
TechCrunch
AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers
10 minutes Posted Aug 20, 2026 at 7:30 am.
0:00
10:40
Download MP3
Show notes
A handful of AI-designed drugs have proceeded into human trials — one as far as Phase III, widespread human testing — but the reality is that the roadblocks aren’t necessarily ones that AI can solve today.
Also, TerraPower's nuclear power plant possesses a strategic advantage over competitors, especially when chasing after data center deals.
Learn more about your ad choices. Visit podcastchoices.com/adchoices